Renaissance Capital is an IPO investment advisory firm providing pre-IPO institutional research and management of IPO-focused funds including the Renaissance IPO ETF (NYSE ticker: IPO), the Renaissance International IPO ETF (NYSE ticker: IPOS) and the Global IPO Mutual Fund (ticker: IPOSX). Through Renaissance Capital’s pre-IPO research service, investors get a hard-nosed, independent opinion, in-depth fundamental analysis and customizable financial models on all IPOs. The Firm's clients also gain access to the premier IPO knowledge base with deal calendars, market commentary, fundamental data on over 5,000 past IPOs and more.
9/2016. looks like growth in technology ( the cloud, artificial intelligence,self driving cars, VR, data cntrs) will continue to drive AVGO, NVDA, QCOM higher, but the best developing opportunity may be in eReits, as rates go up, many will find themselves under water on buys the last few yrs. On health care, while it would be hard to get a cap on drug prices through congress, a decrease in benefits via medicare and ACA, will accomplish the same thing, by giving people less to spend, so I am not interested in any new health care purchases, no matter what the story.
My education includes a BSEE and an MBA. I am retired from a 35 year career as an engineer, and 5 years as an educator in a college business department. I am married, with 2 sons, 6 grandchildren and 2 great-grandchildren. I have been a very active (daily) investor for the past 11 years, but I would not call myself a day trader, more like a frequent trader. My portfolio is conservative, with a preference for individual issues, although I occasionally use ETFs. I reserve a modest portion of my stock allocation for more aggressive investing.